The advent of gene editing technologies, such as CRISPR-Cas9, offers the potential to directly modify genes responsible for susceptibility to certain toxins. This technique could be used to develop resistance to specific poisons, providing a proactive rather than reactive form of treatment. Research is ongoing, and ethical considerations remain paramount.
